| Record ID | ia:overviewofcannab0000king |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/overviewofcannab0000king/overviewofcannab0000king_marc.xml |
| Download MARC binary | https://www.archive.org/download/overviewofcannab0000king/overviewofcannab0000king_meta.mrc |
LEADER: 01222cam a22003494a 4500
001 2006418222
003 DLC
005 20060825121658.0
008 040915s2004 lu a bs 000 0 eng c
010 $a 2006418222
020 $a9291681849 (alk. paper)
035 $a(OCoLC)ocm56733649
040 $aNLM$cNLM$dYUS$dNLGGC$dCOO$dDLC
042 $apcc
050 00 $aHV5840.E85$bK55 2004
082 00 $a615/.7827$222
060 00 $a2004 K-489
060 10 $aQV 16$bK53o 2004
084 $a71.66$2bcl
084 $a71.65$2bcl
100 1 $aKing, L. A.$q(Leslie A.)
245 13 $aAn overview of cannabis potency in Europe /$cprepared by Leslie A. King ; EMCDDA project group, Chloé Carpentier, Paul Griffiths.
260 $aLuxembourg :$bOffice for Official Publications of the European Communities,$c2004.
300 $a71 p. :$bill. ;$c20 cm.
490 1 $aEMCDDA insights ;$v6
504 $aIncludes bibliographical references (p. 65-70).
650 0 $aCannabis$xHealth aspects$zEurope.
700 1 $aCarpentier, Chloé.
700 1 $aGriffiths, Paul.
710 2 $aEuropean Monitoring Centre for Drugs and Drug Addiction.
830 0 $aEMCDDA insights series ;$v6.
856 42 $uhttp://www.emcdda.eu.int/?nnodeid=429